Medtronic Insulin Pump Recall Lawsuit
Case Overview
The lawsuit was initiated by plaintiffs Linda Dorn and Brooke Vasquez against Medtronic MiniMed Inc., Medtronic Inc., and MiniMed Group Inc. They claim that Medtronic sold insulin pumps equipped with a defective retainer ring. This defect can cause the ring to break or detach, leading to incorrect insulin delivery from the pumps.
The allegations assert that Medtronic was negligent, particularly in its handling of a U.S. Food and Drug Administration (FDA) Class I recall notice from February 2020. Plaintiffs argue that despite recalls, the company continued to sell pumps with a redesigned black retainer ring that still presented similar issues. The claims involve strict product liability, negligence, and intentional misrepresentation.
Both plaintiffs have incurred medical expenses and emotional distress due to the malfunctioning devices. They are demanding a jury trial and various damages. The lawsuit is currently active, and plaintiffs are represented by C. Moze Cowper and Paige Miller of Cowper Law LLP.
,Who May Qualify
Individuals who used Medtronic 600 Series insulin pumps that allegedly contained a defective retainer ring.
Frequently Asked Questions
What is the core issue in the Medtronic lawsuit?
The lawsuit centers on the claim that Medtronic's insulin pumps have a defective retainer ring. This defect can cause the pump to deliver too much or too little insulin, potentially leading to severe medical events like seizures or death.
What legal claims are the plaintiffs making against Medtronic?
The plaintiffs allege that Medtronic is guilty of strict product liability, negligence, intentional misrepresentation/concealment, and negligent misrepresentation or concealment regarding the safety of the insulin pumps.